SIMILAR PATTERNS OF AMINO ACIDS FOR 1BCU_H_PRLH280_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1a0j | TRYPSIN (Salmo salar) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | BEN A 246 (-3.0A)SO4 A 248 ( 2.5A)NoneNoneBEN A 246 ( 3.9A)BEN A 246 (-3.3A) | 0.34A | 1bcuH-1a0jA:18.8 | 1bcuH-1a0jA:37.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1a5i | PLASMINOGENACTIVATOR (Desmodusrotundus) |
PF00089(Trypsin) | 6 | ASP A 189ALA A 190SER A 195TRP A 215GLY A 216GLY A 226 | 0GJ A 245 (-3.1A)0GJ A 245 (-3.4A)0GJ A 245 (-1.4A)None0GJ A 245 (-3.5A)0GJ A 245 ( 4.2A) | 0.31A | 1bcuH-1a5iA:16.5 | 1bcuH-1a5iA:32.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1afq | BOVINEGAMMA-CHYMOTRYPSIN (Bos taurus) |
PF00089(Trypsin) | 5 | SER C 195VAL C 213TRP C 215GLY C 216GLY C 226 | 0FG C 301 ( 3.0A)NoneNone0FG C 301 (-3.4A)0FG C 301 ( 4.4A) | 0.26A | 1bcuH-1afqC:9.7 | 1bcuH-1afqC:20.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1bqy | PLASMINOGENACTIVATOR (Trimeresurusstejnegeri) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | 0GJ A 1 (-3.1A)0GJ A 1 ( 1.4A)NoneNone0GJ A 1 (-3.5A)0GJ A 1 ( 4.3A) | 0.33A | 1bcuH-1bqyA:17.3 | 1bcuH-1bqyA:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dlk | THROMBIN HEAVY CHAIN (Bos taurus) |
PF00089(Trypsin) | 5 | SER B 195VAL B 213TRP B 215GLY B 216GLY B 226 | None | 0.26A | 1bcuH-1dlkB:35.3 | 1bcuH-1dlkB:35.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dp2 | RHODANESE (Bos taurus) |
PF00581(Rhodanese) | 5 | ASP A 99ALA A 108VAL A 125GLY A 104GLY A 129 | None | 1.19A | 1bcuH-1dp2A:undetectable | 1bcuH-1dp2A:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1elv | COMPLEMENT C1SCOMPONENT (Homo sapiens) |
PF00084(Sushi)PF00089(Trypsin) | 6 | ASP A 611SER A 617VAL A 638TRP A 640GLY A 641GLY A 648 | NoneSO4 A2001 ( 2.7A)NoneNoneNoneNone | 0.40A | 1bcuH-1elvA:32.3 | 1bcuH-1elvA:28.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ept | PORCINE E-TRYPSIN (Sus scrofa) |
PF00089(Trypsin) | 6 | ASP C 189SER C 195VAL C 213TRP C 215GLY C 216GLY C 226 | None | 0.41A | 1bcuH-1eptC:10.3 | 1bcuH-1eptC:22.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fiw | BETA-ACROSIN HEAVYCHAIN (Ovis aries) |
PF00089(Trypsin) | 5 | ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | PBZ A 305 (-2.7A)PBZ A 305 (-2.9A)NonePBZ A 305 (-3.4A)PBZ A 305 (-3.3A) | 0.38A | 1bcuH-1fiwA:35.4 | 1bcuH-1fiwA:31.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fiz | BETA-ACROSIN HEAVYCHAIN (Sus scrofa) |
PF00089(Trypsin) | 5 | ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | PBZ A 308 (-2.9A)PBZ A 308 (-3.2A)NonePBZ A 308 (-3.6A)PBZ A 308 ( 3.7A) | 0.52A | 1bcuH-1fizA:17.5 | 1bcuH-1fizA:35.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fxy | COAGULATION FACTORXA-TRYPSIN CHIMERA (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | 0G6 A 1 (-2.8A)0G6 A 1 (-1.4A)NoneNone0G6 A 1 (-3.9A)0G6 A 1 (-3.3A) | 0.47A | 1bcuH-1fxyA:18.3 | 1bcuH-1fxyA:37.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1gvl | KALLIKREIN 6 (Homo sapiens) |
PF00089(Trypsin) | 5 | SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | None | 0.70A | 1bcuH-1gvlA:10.2 | 1bcuH-1gvlA:37.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1h4w | TRYPSIN IVA (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | BEN A 250 (-2.9A)BEN A 250 (-3.6A)NoneNoneBEN A 250 (-3.9A)BEN A 250 (-3.3A) | 0.32A | 1bcuH-1h4wA:18.6 | 1bcuH-1h4wA:37.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1h9h | TRYPSIN (Sus scrofa) |
PF00089(Trypsin) | 6 | ASP E 189SER E 195VAL E 213TRP E 215GLY E 216GLY E 226 | None | 0.43A | 1bcuH-1h9hE:18.4 | 1bcuH-1h9hE:38.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1id5 | THROMBIN (Bos taurus) |
PF00089(Trypsin) | 7 | ASP H 189ALA H 190GLU H 192VAL H 213TRP H 215GLY H 216GLY H 226 | None | 0.41A | 1bcuH-1id5H:43.3 | 1bcuH-1id5H:87.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1id5 | THROMBIN (Bos taurus) |
PF00089(Trypsin) | 7 | ASP H 189ALA H 190SER H 195VAL H 213TRP H 215GLY H 216GLY H 226 | None | 0.45A | 1bcuH-1id5H:43.3 | 1bcuH-1id5H:87.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1j17 | TRYPSIN II, ANIONIC (Rattusnorvegicus) |
PF00089(Trypsin) | 7 | ASP T 189ALA T 190SER T 195VAL T 213TRP T 215GLY T 216GLY T 226 | ZEN T 1 ( 3.8A)ZEN T 1 (-3.8A)SO4 T 600 ( 2.6A)ZEN T 1 (-4.1A)ZEN T 1 (-3.4A)ZEN T 1 (-3.7A)ZEN T 1 (-3.7A) | 0.32A | 1bcuH-1j17T:18.7 | 1bcuH-1j17T:37.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1kig | FACTOR XA (Bos taurus) |
PF00089(Trypsin) | 7 | ASP H 189ALA H 190SER H 195VAL H 213TRP H 215GLY H 216GLY H 226 | None | 0.42A | 1bcuH-1kigH:35.3 | 1bcuH-1kigH:39.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1mbq | TRYPSIN (Oncorhynchusketa) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | BEN A1222 (-2.9A)BEN A1222 (-3.5A)NoneNoneBEN A1222 (-3.9A)BEN A1222 (-3.4A) | 0.34A | 1bcuH-1mbqA:18.2 | 1bcuH-1mbqA:37.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1n5x | XANTHINEDEHYDROGENASE (Bos taurus) |
PF00111(Fer2)PF00941(FAD_binding_5)PF01315(Ald_Xan_dh_C)PF01799(Fer2_2)PF02738(Ald_Xan_dh_C2)PF03450(CO_deh_flav_C) | 5 | ASP A 429ALA A 338VAL A 342GLY A 47GLY A 145 | FAD A3005 (-4.1A)FAD A3005 (-3.5A)NoneFAD A3005 (-4.0A)None | 1.04A | 1bcuH-1n5xA:undetectable | 1bcuH-1n5xA:11.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1npm | NEUROPSIN (Mus musculus) |
PF00089(Trypsin) | 5 | ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.29A | 1bcuH-1npmA:17.9 | 1bcuH-1npmA:33.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1o5f | SERINE PROTEASEHEPSIN (Homo sapiens) |
PF00089(Trypsin) | 7 | ASP H 189ALA H 190SER H 195VAL H 213TRP H 215GLY H 216GLY H 226 | CR9 H 256 (-2.4A)CR9 H 256 (-2.9A)CR9 H 256 (-1.5A)CR9 H 256 (-4.3A)NoneCR9 H 256 ( 3.8A)CR9 H 256 (-3.0A) | 0.32A | 1bcuH-1o5fH:35.7 | 1bcuH-1o5fH:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1op2 | VENOM SERINEPROTEINASE (Deinagkistrodonacutus) |
PF00089(Trypsin) | 5 | ASP A 189SER A 195VAL A 213GLY A 216GLY A 226 | None | 0.23A | 1bcuH-1op2A:16.4 | 1bcuH-1op2A:32.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pfx | FACTOR IXA (Sus scrofa) |
PF00089(Trypsin) | 5 | ASP C 189SER C 195TRP C 215GLY C 216GLY C 226 | 0G6 C 301 (-3.0A)0G6 C 301 (-1.4A)None0G6 C 301 (-3.2A)0G6 C 301 ( 3.5A) | 0.49A | 1bcuH-1pfxC:34.2 | 1bcuH-1pfxC:37.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pq5 | TRYPSIN (Fusariumoxysporum) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 210TRP A 212GLY A 213GLY A 223 | ARG A 703 (-2.0A)ARG A 703 (-2.3A)ARG A 703 (-4.5A)NoneARG A 703 ( 3.7A)ARG A 703 (-2.6A) | 0.40A | 1bcuH-1pq5A:33.3 | 1bcuH-1pq5A:34.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q3x | MANNAN-BINDINGLECTIN SERINEPROTEASE 2 (Homo sapiens) |
PF00084(Sushi)PF00089(Trypsin) | 6 | ASP A 627SER A 633VAL A 653TRP A 655GLY A 656GLY A 667 | NA A 800 ( 4.6A)GOL A 701 (-3.0A)GOL A 701 (-4.9A)NoneGOL A 701 ( 4.1A)GOL A 701 ( 4.0A) | 0.43A | 1bcuH-1q3xA:35.9 | 1bcuH-1q3xA:28.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rk2 | RIBOKINASE (Escherichiacoli) |
PF00294(PfkB) | 5 | ALA A 209GLU A 214VAL A 220GLY A 235GLY A 237 | None | 1.17A | 1bcuH-1rk2A:undetectable | 1bcuH-1rk2A:20.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1sgf | NERVE GROWTH FACTOR (Mus musculus) |
PF00089(Trypsin) | 5 | ASP G 189SER G 195TRP G 215GLY G 216GLY G 226 | None | 0.33A | 1bcuH-1sgfG:17.3 | 1bcuH-1sgfG:32.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ur4 | GALACTANASE (Bacilluslicheniformis) |
PF07745(Glyco_hydro_53) | 5 | GLU A 38VAL A 327TRP A 324GLY A 346GLY A 366 | None | 1.32A | 1bcuH-1ur4A:undetectable | 1bcuH-1ur4A:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ur4 | GALACTANASE (Bacilluslicheniformis) |
PF07745(Glyco_hydro_53) | 5 | SER A 39VAL A 327TRP A 324GLY A 346GLY A 366 | None | 1.01A | 1bcuH-1ur4A:undetectable | 1bcuH-1ur4A:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xb2 | ELONGATION FACTORTS, MITOCHONDRIAL (Bos taurus) |
PF00889(EF_TS) | 5 | GLU B 117SER B 142GLY B 245CYH B 328GLY B 121 | None | 1.22A | 1bcuH-1xb2B:undetectable | 1bcuH-1xb2B:19.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ym0 | FIBRINOTIC ENZYMECOMPONENT B (Eisenia fetida) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | None | 0.38A | 1bcuH-1ym0A:36.3 | 1bcuH-1ym0A:33.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ysr | SENSOR-TYPEHISTIDINE KINASEPRRB (Mycobacteriumtuberculosis) |
PF02518(HATPase_c) | 5 | ASP A 380ALA A 436VAL A 385GLY A 358GLY A 382 | None | 1.29A | 1bcuH-1ysrA:undetectable | 1bcuH-1ysrA:21.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zlr | COAGULATION FACTORXI (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189ALA A 190SER A 195TRP A 215GLY A 216GLY A 226 | 368 A 901 (-2.8A)368 A 901 (-3.7A)368 A 901 (-1.4A)None368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.32A | 1bcuH-1zlrA:35.6 | 1bcuH-1zlrA:37.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2e1t | ACYL TRANSFERASE (Chrysanthemum xmorifolium) |
PF02458(Transferase) | 5 | ASP A 33VAL A 321GLY A 173CYH A 171GLY A 318 | NoneMLC A1001 ( 4.9A)NoneNoneNone | 1.37A | 1bcuH-2e1tA:undetectable | 1bcuH-2e1tA:22.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2eek | TRYPSIN-1 (Gadus morhua) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | BEN A 301 (-2.7A)BEN A 301 (-3.4A)NoneNoneBEN A 301 ( 3.8A)BEN A 301 (-3.2A) | 0.29A | 1bcuH-2eekA:18.0 | 1bcuH-2eekA:38.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ei8 | COAGULATION FACTORX, HEAVY CHAIN (Homo sapiens) |
PF00089(Trypsin) | 7 | ASP A 189ALA A 190SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | DT8 A 700 (-3.5A)DT8 A 700 (-3.6A)DT8 A 700 ( 3.9A)DT8 A 700 ( 4.1A)DT8 A 700 (-3.9A)DT8 A 700 (-3.5A)DT8 A 700 (-3.5A) | 0.31A | 1bcuH-2ei8A:36.2 | 1bcuH-2ei8A:40.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ei8 | COAGULATION FACTORX, HEAVY CHAIN (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP A 189ALA A 190VAL A 138GLY A 226GLY A 184 | DT8 A 700 (-3.5A)DT8 A 700 (-3.6A)NoneDT8 A 700 (-3.5A)None | 1.23A | 1bcuH-2ei8A:36.2 | 1bcuH-2ei8A:40.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2f91 | HEPATOPANCREASTRYPSIN (Astacusleptodactylus) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 227 | None | 0.39A | 1bcuH-2f91A:35.2 | 1bcuH-2f91A:36.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hqb | TRANSCRIPTIONALACTIVATOR OF COMKGENE (Bacillushalodurans) |
PF02608(Bmp) | 5 | ALA A 115GLU A 147VAL A 123GLY A 141GLY A 111 | None | 1.04A | 1bcuH-2hqbA:undetectable | 1bcuH-2hqbA:21.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ivp | O-SIALOGLYCOPROTEINENDOPEPTIDASE (Pyrococcusabyssi) |
PF00814(Peptidase_M22) | 5 | ASP A 159GLU A 164VAL A 175GLY A 168GLY A 171 | ATP A1327 (-2.7A)NoneNoneNoneATP A1327 ( 4.4A) | 1.33A | 1bcuH-2ivpA:undetectable | 1bcuH-2ivpA:21.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jet | CHYMOTRYPSINOGEN BCHAIN C (Rattusnorvegicus) |
PF00089(Trypsin) | 5 | SER C 195VAL C 213TRP C 215GLY C 216GLY C 226 | None | 0.57A | 1bcuH-2jetC:8.3 | 1bcuH-2jetC:24.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2opu | KHSRP PROTEIN (Homo sapiens) |
PF00013(KH_1) | 5 | ALA A 79GLU A 22VAL A 53GLY A 71GLY A 50 | None | 1.09A | 1bcuH-2opuA:undetectable | 1bcuH-2opuA:15.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oq5 | TRANSMEMBRANEPROTEASE, SERINE 11E (Homo sapiens) |
PF00089(Trypsin) | 7 | ASP A 189ALA A 190SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | BEN A 245 (-3.0A)BEN A 245 (-3.9A)BEN A 245 (-3.3A)NoneNoneBEN A 245 ( 3.8A)BEN A 245 (-3.4A) | 0.34A | 1bcuH-2oq5A:35.4 | 1bcuH-2oq5A:37.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oxt | NUCLEOSIDE-2'-O-METHYLTRANSFERASE (Meaban virus) |
PF01728(FtsJ) | 5 | ASP A 80ALA A 103SER A 129GLY A 84GLY A 82 | SAM A 300 ( 4.6A)NoneNoneSAM A 300 (-3.5A)SAM A 300 (-3.3A) | 1.25A | 1bcuH-2oxtA:undetectable | 1bcuH-2oxtA:20.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pks | THROMBIN HEAVY CHAINFRAGMENT (Homo sapiens) |
PF00089(Trypsin) | 5 | ALA C 230GLU C 232SER C 235VAL C 255TRP C 257 | G44 C 101 (-3.8A)NoneG44 C 101 (-3.5A)NoneG44 C 101 (-4.1A) | 0.85A | 1bcuH-2pksC:14.2 | 1bcuH-2pksC:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pks | THROMBIN HEAVY CHAINFRAGMENT (Homo sapiens) |
PF00089(Trypsin) | 7 | ASP C 229ALA C 230SER C 235VAL C 255TRP C 257GLY C 258GLY C 268 | G44 C 101 (-2.6A)G44 C 101 (-3.8A)G44 C 101 (-3.5A)NoneG44 C 101 (-4.1A)G44 C 101 (-3.3A)G44 C 101 (-3.0A) | 0.27A | 1bcuH-2pksC:14.2 | 1bcuH-2pksC:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2psy | KALLIKREIN-5 (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | None | 0.42A | 1bcuH-2psyA:17.9 | 1bcuH-2psyA:34.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qy0 | COMPLEMENT C1RSUBCOMPONENT (Homo sapiens) |
PF00089(Trypsin) | 7 | ASP B 631ALA B 632SER B 637VAL B 657TRP B 659GLY B 660GLY B 668 | None | 0.37A | 1bcuH-2qy0B:34.0 | 1bcuH-2qy0B:38.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r0l | HEPATOCYTE GROWTHFACTOR ACTIVATOR (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189ALA A 190SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.39A | 1bcuH-2r0lA:35.3 | 1bcuH-2r0lA:35.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r2w | PLASMINOGENACTIVATOR, UROKINASE (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP U 189VAL U 213TRP U 215GLY U 216GLY U 226 | 4PG U 300 (-2.8A)NoneNone4PG U 300 (-3.3A)4PG U 300 (-3.2A) | 0.40A | 1bcuH-2r2wU:35.7 | 1bcuH-2r2wU:32.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vp1 | PERIPLASMICIRON-BINDING PROTEIN (Synechocystissp. PCC 6803) |
PF13343(SBP_bac_6) | 5 | ASP A 87ALA A 88GLU A 95VAL A 326GLY A 330 | None | 0.97A | 1bcuH-2vp1A:undetectable | 1bcuH-2vp1A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wa2 | NON-STRUCTURALPROTEIN 5 (Modoc virus) |
PF01728(FtsJ) | 5 | ASP A 80ALA A 103SER A 129GLY A 84GLY A 82 | SAM A1248 ( 4.9A)NoneNoneSAM A1248 (-3.4A)SAM A1248 (-3.3A) | 1.23A | 1bcuH-2wa2A:undetectable | 1bcuH-2wa2A:19.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2wpm | COAGULATION FACTORIXA HEAVY CHAIN (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP S 189SER S 195TRP S 215GLY S 216GLY S 226 | None | 0.45A | 1bcuH-2wpmS:35.7 | 1bcuH-2wpmS:37.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xxl | GRAM-POSITIVESPECIFIC SERINEPROTEASE, ISOFORM B (Drosophilamelanogaster) |
PF00089(Trypsin)PF12032(CLIP) | 5 | GLU A 269SER A 318VAL A 342GLY A 345GLY A 356 | NAG A1385 (-4.0A)NoneNoneNoneNone | 1.31A | 1bcuH-2xxlA:28.1 | 1bcuH-2xxlA:25.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zec | TRYPTASE BETA 2 (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 203SER A 209VAL A 227TRP A 229GLY A 230GLY A 240 | 11N A 1 (-2.6A)11N A 1 (-3.3A)NoneNone11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.52A | 1bcuH-2zecA:33.7 | 1bcuH-2zecA:35.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3beu | TRYPSIN (Streptomycesgriseus) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | BEN A 247 (-3.0A)SO4 A 246 ( 2.5A)NoneNoneBEN A 247 (-3.7A)BEN A 247 (-3.5A) | 0.25A | 1bcuH-3beuA:32.2 | 1bcuH-3beuA:34.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3f6u | VITAMIN K-DEPENDENTPROTEIN C HEAVYCHAIN (Homo sapiens) |
PF00089(Trypsin) | 7 | ASP H 189ALA H 190SER H 195VAL H 213TRP H 215GLY H 216GLY H 226 | 0G6 H 1 (-2.8A)0G6 H 1 (-3.4A)0G6 H 1 (-1.8A)None0G6 H 1 (-4.1A)0G6 H 1 (-3.8A)0G6 H 1 ( 3.9A) | 0.37A | 1bcuH-3f6uH:36.4 | 1bcuH-3f6uH:40.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gov | MASP-1 (Homo sapiens) |
PF00089(Trypsin) | 7 | ASP B 640ALA B 641SER B 646VAL B 666TRP B 668GLY B 669GLY B 679 | None | 0.38A | 1bcuH-3govB:37.2 | 1bcuH-3govB:36.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gym | PROSTASIN (Homo sapiens) |
PF00089(Trypsin) | 7 | ASP A 189ALA A 190SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | None | 0.39A | 1bcuH-3gymA:34.4 | 1bcuH-3gymA:36.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jav | INOSITOL1,4,5-TRISPHOSPHATERECEPTOR TYPE 1 (Rattusnorvegicus) |
PF00520(Ion_trans)PF01365(RYDR_ITPR)PF02815(MIR)PF08454(RIH_assoc)PF08709(Ins145_P3_rec) | 5 | ASP A 228ALA A 296SER A 301GLY A 236GLY A 294 | None | 1.32A | 1bcuH-3javA:undetectable | 1bcuH-3javA:6.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3me8 | PUTATIVEUNCHARACTERIZEDPROTEIN (Aquifexaeolicus) |
PF02630(SCO1-SenC) | 5 | ASP A 91VAL A 67TRP A 66GLY A 62GLY A 94 | None | 1.30A | 1bcuH-3me8A:undetectable | 1bcuH-3me8A:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3olz | GLUTAMATE RECEPTOR,IONOTROPIC KAINATE 3 (Rattusnorvegicus) |
PF01094(ANF_receptor) | 5 | ASP A 134ALA A 131GLU A 159SER A 127GLY A 382 | None | 1.03A | 1bcuH-3olzA:undetectable | 1bcuH-3olzA:20.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3r3g | THROMBIN HEAVY CHAIN (Homo sapiens) |
PF00089(Trypsin) | 7 | ASP B 189ALA B 190SER B 195VAL B 213TRP B 215GLY B 216GLY B 226 | None | 0.16A | 1bcuH-3r3gB:44.7 | 1bcuH-3r3gB:97.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rcn | BETA-N-ACETYLHEXOSAMINIDASE (Paenarthrobacteraurescens) |
PF00728(Glyco_hydro_20)PF02838(Glyco_hydro_20b) | 5 | ALA A 388GLU A 364VAL A 395GLY A 392GLY A 444 | None | 1.30A | 1bcuH-3rcnA:undetectable | 1bcuH-3rcnA:17.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3s69 | THROMBIN-LIKE ENZYMEDEFIBRASE (Gloydiussaxatilis) |
PF00089(Trypsin) | 5 | ASP A 189SER A 195VAL A 209GLY A 212GLY A 223 | None | 0.32A | 1bcuH-3s69A:16.4 | 1bcuH-3s69A:31.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3syj | ADHESION ANDPENETRATION PROTEINAUTOTRANSPORTER (Haemophilusinfluenzae) |
PF02395(Peptidase_S6)PF03212(Pertactin) | 5 | GLU A 473SER A 450VAL A 451GLY A 499GLY A 502 | None | 1.31A | 1bcuH-3syjA:15.6 | 1bcuH-3syjA:12.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bin | N-ACETYLMURAMOYL-L-ALANINE AMIDASE AMIC (Escherichiacoli) |
PF01520(Amidase_3)PF11741(AMIN) | 5 | ASP A 267ALA A 266GLU A 383VAL A 215GLY A 202 | ZN A 500 (-2.3A)NoneNoneNoneNone | 1.07A | 1bcuH-4binA:undetectable | 1bcuH-4binA:19.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bxw | FACTOR XA (Pseudonajatextilis) |
PF00089(Trypsin)PF14670(FXa_inhibition) | 6 | ASP A 356ALA A 357SER A 362VAL A 380GLY A 383GLY A 393 | 0GJ A1411 (-2.7A)0GJ A1411 (-3.4A)0GJ A1411 (-1.4A)None0GJ A1411 (-3.7A)0GJ A1411 (-3.3A) | 0.37A | 1bcuH-4bxwA:34.2 | 1bcuH-4bxwA:25.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4fxg | MANNAN-BINDINGLECTIN SERINEPROTEASE 2 B CHAIN (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP H 627VAL H 653TRP H 655GLY H 656GLY H 667 | None | 0.37A | 1bcuH-4fxgH:36.1 | 1bcuH-4fxgH:35.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4gso | THROMBIN-LIKE ENZYMEBJUSSUSP-1 (Bothropsjararacussu) |
PF00089(Trypsin) | 5 | ASP A 172SER A 178VAL A 192GLY A 195GLY A 206 | None | 0.44A | 1bcuH-4gsoA:undetectable | 1bcuH-4gsoA:33.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gt6 | CELL SURFACE PROTEIN (Faecalibacteriumprausnitzii) |
PF13306(LRR_5) | 5 | ASP A 258ALA A 280GLU A 283SER A 304VAL A 303 | None | 1.28A | 1bcuH-4gt6A:undetectable | 1bcuH-4gt6A:21.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iw4 | MANNAN-BINDINGLECTIN SERINEPROTEASE 3 (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP E 639SER E 645VAL E 665TRP E 667GLY E 668GLY E 680 | None | 0.58A | 1bcuH-4iw4E:34.0 | 1bcuH-4iw4E:35.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k8y | KALLIKREIN-4 (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP A 189SER A 195VAL A 213GLY A 216GLY A 226 | None | 0.44A | 1bcuH-4k8yA:17.4 | 1bcuH-4k8yA:35.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4m7g | TRYPSIN-LIKEPROTEASE (Saccharopolysporaerythraea) |
PF00089(Trypsin) | 5 | ASP A 173SER A 179TRP A 195GLY A 196GLY A 206 | None | 0.44A | 1bcuH-4m7gA:18.0 | 1bcuH-4m7gA:32.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | 3KM A 900 (-2.9A)3KM A 900 (-3.6A)NoneNone3KM A 900 (-3.4A)3KM A 900 (-3.2A) | 0.32A | 1bcuH-4r0iA:37.3 | 1bcuH-4r0iA:35.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rz2 | SITE-DETERMININGPROTEIN (Geobacillusthermodenitrificans) |
PF10609(ParA) | 5 | ASP A 58ALA A 103SER A 74GLY A 62GLY A 105 | None | 1.18A | 1bcuH-4rz2A:undetectable | 1bcuH-4rz2A:22.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4u83 | ACYL-COADEHYDROGENASE (Brucellaabortus) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 5 | ALA A 68GLU A 305VAL A 297GLY A 239GLY A 243 | None | 1.26A | 1bcuH-4u83A:undetectable | 1bcuH-4u83A:20.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wwy | TRYPSIN-1 (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | None | 0.43A | 1bcuH-4wwyA:18.4 | 1bcuH-4wwyA:36.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ylq | COAGULATION FACTORVII (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP H 189SER H 195VAL H 213TRP H 215GLY H 216GLY H 226 | 0Z7 H 501 (-2.3A)0Z7 H 501 (-1.4A)0Z7 H 501 ( 4.7A)TMA H 508 ( 3.9A)0Z7 H 501 (-3.4A)0Z7 H 501 (-3.0A) | 0.41A | 1bcuH-4ylqH:35.3 | 1bcuH-4ylqH:35.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) |
PF00111(Fer2)PF00941(FAD_binding_5)PF01315(Ald_Xan_dh_C)PF01799(Fer2_2)PF02738(Ald_Xan_dh_C2)PF03450(CO_deh_flav_C) | 5 | ASP A 428ALA A 337VAL A 341GLY A 47GLY A 144 | FAD A3004 (-3.7A)FAD A3004 (-3.4A)FAD A3004 (-4.9A)FES A3002 (-4.4A)None | 1.16A | 1bcuH-4yswA:undetectable | 1bcuH-4yswA:10.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5brr | TISSUE-TYPEPLASMINOGENACTIVATOR (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP E 189ALA E 190TRP E 215GLY E 216GLY E 226 | None | 0.35A | 1bcuH-5brrE:35.6 | 1bcuH-5brrE:32.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5f8z | PLASMA KALLIKREINLIGHT CHAIN (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189ALA A 190SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.51A | 1bcuH-5f8zA:35.6 | 1bcuH-5f8zA:39.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5fah | KALLIKREIN-7 (Homo sapiens) |
PF00089(Trypsin) | 5 | ALA A 190SER A 195VAL A 213TRP A 215GLY A 226 | 5VT A 302 (-3.8A)5VT A 302 (-4.0A)NoneNone5VT A 302 ( 4.3A) | 0.88A | 1bcuH-5fahA:16.3 | 1bcuH-5fahA:33.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5fah | KALLIKREIN-7 (Homo sapiens) |
PF00089(Trypsin) | 5 | ALA A 190VAL A 213TRP A 215GLY A 216GLY A 226 | 5VT A 302 (-3.8A)NoneNone5VT A 302 (-3.4A)5VT A 302 ( 4.3A) | 0.44A | 1bcuH-5fahA:16.3 | 1bcuH-5fahA:33.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gvt | PLASMA KALLIKREIN (Mus musculus) |
no annotation | 5 | ASP A 189ALA A 190SER A 195GLY A 216GLY A 226 | None | 0.46A | 1bcuH-5gvtA:35.5 | 1bcuH-5gvtA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gvt | PLASMA KALLIKREIN (Mus musculus) |
no annotation | 5 | ASP A 189ALA A 190SER A 195TRP A 215GLY A 226 | None | 1.25A | 1bcuH-5gvtA:35.5 | 1bcuH-5gvtA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j44 | SERINE PROTEASE SEPAAUTOTRANSPORTER (Shigellaflexneri) |
PF02395(Peptidase_S6) | 5 | ASP A 461ALA A 460SER A 437GLY A 442GLY A 463 | None | 1.25A | 1bcuH-5j44A:17.3 | 1bcuH-5j44A:13.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ms3 | KALLIKREIN-8 (Homo sapiens) |
no annotation | 5 | ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | None | 0.28A | 1bcuH-5ms3A:17.8 | 1bcuH-5ms3A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n0g | PRECORRIN-8XMETHYLMUTASE (Rhodobactercapsulatus) |
no annotation | 5 | ASP A 76ALA A 77GLU A 82CYH A 75GLY A 135 | None | 1.25A | 1bcuH-5n0gA:undetectable | 1bcuH-5n0gA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5o32 | COMPLEMENT FACTOR I (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP I 519ALA I 520VAL I 544TRP I 546GLY I 547GLY I 557 | None | 0.94A | 1bcuH-5o32I:31.9 | 1bcuH-5o32I:33.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5to3 | PROTHROMBIN,THROMBOMODULIN (Homo sapiens) |
PF00089(Trypsin)PF09064(Tme5_EGF_like) | 5 | ASP B 214ALA B 215GLU B 217GLY B 243GLY B 253 | 0G6 B 501 (-2.9A)0G6 B 501 (-3.4A)0G6 B 501 (-3.8A)0G6 B 501 (-3.7A)0G6 B 501 (-3.6A) | 0.86A | 1bcuH-5to3B:46.3 | 1bcuH-5to3B:88.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5to3 | PROTHROMBIN,THROMBOMODULIN (Homo sapiens) |
PF00089(Trypsin)PF09064(Tme5_EGF_like) | 6 | ASP B 214ALA B 215SER B 220VAL B 240GLY B 243GLY B 253 | 0G6 B 501 (-2.9A)0G6 B 501 (-3.4A)0G6 B 501 (-1.3A)None0G6 B 501 (-3.7A)0G6 B 501 (-3.6A) | 0.31A | 1bcuH-5to3B:46.3 | 1bcuH-5to3B:88.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ubm | COMPLEMENT C1SSUBCOMPONENT (Homo sapiens) |
no annotation | 6 | ASP A 626SER A 632VAL A 653TRP A 655GLY A 656GLY A 663 | None | 0.59A | 1bcuH-5ubmA:32.9 | 1bcuH-5ubmA:35.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uni | NAD(P)TRANSHYDROGENASESUBUNIT BETA (Thermusthermophilus) |
PF02233(PNTB) | 5 | ALA B 96GLU B 103VAL B 218GLY B 122GLY B 125 | NoneBEN B 310 (-3.3A)NoneNoneNone | 1.28A | 1bcuH-5uniB:undetectable | 1bcuH-5uniB:20.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xrf | SNAKE VENOM SERINEPROTEASE DA-36 (Deinagkistrodonacutus) |
no annotation | 5 | ASP A 200SER A 206VAL A 220GLY A 223GLY A 234 | None | 0.58A | 1bcuH-5xrfA:15.3 | 1bcuH-5xrfA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yh1 | - (-) |
no annotation | 5 | ASP A 366ALA A 498GLU A 504VAL A 435GLY A 367 | MN A 805 (-3.1A) MN A 805 ( 4.6A)NoneNoneNone | 1.35A | 1bcuH-5yh1A:undetectable | 1bcuH-5yh1A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5zfh | KALLIKREIN-7 (Mus musculus) |
no annotation | 5 | SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | None | 0.35A | 1bcuH-5zfhA:18.1 | 1bcuH-5zfhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6b74 | COAGULATION FACTORXII (Homo sapiens) |
no annotation | 6 | ASP B 189ALA B 190SER B 195TRP B 215GLY B 216GLY B 226 | BEN B 301 (-2.7A)BEN B 301 (-4.1A)SO4 B 304 ( 2.5A)NoneBEN B 301 (-3.3A)BEN B 301 (-3.1A) | 0.41A | 1bcuH-6b74B:34.9 | 1bcuH-6b74B:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6brk | DEOXYNUCLEOSIDETRIPHOSPHATETRIPHOSPHOHYDROLASESAMHD1 (Mus musculus) |
no annotation | 5 | ALA A 234GLU A 266SER A 334VAL A 333GLY A 204 | NoneDGT A 701 (-4.2A)NoneNoneNone | 1.27A | 1bcuH-6brkA:undetectable | 1bcuH-6brkA:undetectable |